Steven Wheen

Stock Analyst at Jarden

(3.95)
# 1,857
Out of 5,133 analysts
250
Total ratings
48.2%
Success rate
7.9%
Average return

Stocks Rated by Steven Wheen

Telix Pharmaceuticals Limited
Nov 5, 2026
Reiterated: Buy
Price Target: $21.00
Current: $13.58
Upside: +54.64%
ResMed Inc.
Nov 2, 2026
Reiterated: Buy
Price Target: $39.90 → $38.70
Current: $34.96
Upside: +10.70%
Integral Diagnostics Limited
Oct 30, 2026
Downgraded: Hold
Price Target: $2.95 → $2.35
Current: $1.67
Upside: +41.14%
Healius Limited
Oct 23, 2026
Reiterated: Hold
Price Target: $0.54 → $0.51
Current: $0.58
Upside: -11.30%
Regis Healthcare Limited
Sep 3, 2026
Reiterated: Hold
Price Target: $7.50 → $6.20
Current: $5.13
Upside: +20.86%
Ramsay Health Care Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $47.60 → $53.00
Current: $55.03
Upside: -3.69%
Sonic Healthcare Limited
Aug 21, 2026
Reiterated: Hold
Price Target: $22.30 → $22.90
Current: $19.89
Upside: +15.13%
Cochlear Limited
Aug 19, 2026
Reiterated: Hold
Price Target: $169.00 → $165.00
Current: $151.37
Upside: +9.00%
CSL Limited
Aug 19, 2026
Upgraded: Buy
Price Target: $191.00 → $207.00
Current: $202.92
Upside: +2.01%
QBE Insurance Group Limited
Feb 20, 2026
Reiterated: Hold
Price Target: $22.00
Current: $26.75
Upside: -17.76%
Reiterated: Hold
Price Target: $0.71 → $0.75
Current: $0.50
Upside: n/a